TADALAFIL PAH Devatis cpr pellic 20 mg 56 pce

7680700010016 CH-70001 G04BE08 02.07.1.

Active substances:

No images available

Details

Product number
7000101
CPT
-
Packaging group
56
Unit
Tablette(n)
Composition
tadalafilum 20 mg, lactosum monohydricum 249 mg, carmellosum natricum conexum, natrii laurilsulfas, hydroxypropylcellulosum, cellulosum microcristallinum, magnesii stearas, Überzug: lactosum monohydricum 3.6 mg, hypromellosum, E 171, E 172 (flavum), triacetinum, talcum, pro compresso obducto corresp. natrium 0.71 mg.

Articles (1)

Tadalafil PAH Devatis 20 mg, Filmtabletten
Filmtabletten
56
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
03/03/2026
Patient information leaflet
Français
03/03/2026
Patient information leaflet
Italien
03/03/2026
Professional SmPC
Allemand
03/03/2026
Professional SmPC
Français
03/03/2026
Professional SmPC
Italien
03/03/2026

Detailed composition

Substance Quantity Type Category
tadalafilum
20.0 MG Substance Wirkstoff (Principe actif)
lactosum monohydricum
249.0 MG Substance HBESI
carmellosum natricum conexum
- Substance HNIDK
natrii laurilsulfas
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
hydroxypropylcellulosum
- Substance HNIDK
cellulosum microcristallinum
- Substance HNIDK
magnesii stearas
- Substance HNIDK
lactosum monohydricum
3.6 MG Substance HBESI
hypromellosum
- Substance HNIDK
E 171
- Substance FNIDK
E 172 (flavum)
- Substance FTODK
triacetinum
- Substance HNIDK
talcum
- Substance HNIDK
natrium
0.71 MG Substance HBESI

Reimbursement information

Public price
CHF 406.15
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/05/2026

Authorization holder

Devatis AG

6330 Cham

Authorization information

Swissmedic authorization number
70001
Drug name
Tadalafil PAH Devatis, Filmtabletten
Galenic form
FILM
ATC Code
G04BE08
Authorization status
Z
Dispensation category
B
First authorization
19/01/2026
Authorization expiration date
18/01/2031
IT number
02.07.1.
Domain
Human medicine
Field of application
Pulmonale arterielle Hypertonie (PAH)

Packaging details

Description (FR)
TADALAFIL PAH Devatis cpr pellic 20 mg 56 pce
Description (DE)
TADALAFIL PAH Devatis Filmtabl 20 mg 56 Stk
Market launch
01/05/2026
Narcotic (BTM)
No

Original drug

Adcirca, comprimés pelliculés
CHF 471.05
View original
Buy us a coffee Explore the data